Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Stoma-free survival after rectal cancer resection with anastomotic leakage : development and validation of a prediction model in a large international cohort
Avtorji:ID Greijdanus, Nynke G. (Avtor)
ID Wienholts, Kiedo (Avtor)
ID Ubels, Sander (Avtor)
ID Talboom, Kevin (Avtor)
ID Hannink, Gerjon (Avtor)
ID Wolthuis, Albert (Avtor)
ID de Lacy, Francisco B (Avtor)
ID Lefevre, Jérémie H (Avtor)
ID Solomon, Michael (Avtor)
ID Frasson, Matteo (Avtor)
ID Grosek, Jan (Sodelavec pri raziskavi)
ID Košir, Jurij Aleš (Sodelavec pri raziskavi)
ID Tomažič, Aleš (Sodelavec pri raziskavi)
ID Košir Božič, Tajda (Sodelavec pri raziskavi), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (311,48 KB)
MD5: 60758B4949EE8A0B26D6F8745AF9C879
 
URL URL - Izvorni URL, za dostop obiščite https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549897/pdf/sla-278-00772.pdf
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Objective: To develop and validate a prediction model (STOMA score) for 1-year stoma-free survival in patients with rectal cancer (RC) with anastomotic leakage (AL). Background: AL after RC resection often results in a permanent stoma. Methods: This international retrospective cohort study (TENTACLE-Rectum) encompassed 216 participating centres and included patients who developed AL after RC surgery between 2014 and 2018. Clinically relevant predictors for 1-year stoma-free survival were included in uni and multivariable logistic regression models. The STOMA score was developed and internally validated in a cohort of patients operated between 2014 and 2017, with subsequent temporal validation in a 2018 cohort. The discriminative power and calibration of the models' performance were evaluated. Results: This study included 2499 patients with AL, 1954 in the development cohort and 545 in the validation cohort. Baseline characteristics were comparable. One-year stoma-free survival was 45.0% in the development cohort and 43.7% in the validation cohort. The following predictors were included in the STOMA score: sex, age, American Society of Anestesiologist classification, body mass index, clinical M-disease, neoadjuvant therapy, abdominal and transanal approach, primary defunctioning stoma, multivisceral resection, clinical setting in which AL was diagnosed, postoperative day of AL diagnosis, abdominal contamination, anastomotic defect circumference, bowel wall ischemia, anastomotic fistula, retraction, and reactivation leakage. The STOMA score showed good discrimination and calibration (c-index: 0.71, 95% CI: 0.66-0.76). Conclusions: The STOMA score consists of 18 clinically relevant factors and estimates the individual risk for 1-year stoma-free survival in patients with AL after RC surgery, which may improve patient counseling and give guidance when analyzing the efficacy of different treatment strategies in future studies.
Ključne besede:anastomotic leakage, rectal cancer, rectal cancer resection, stoma-free survival permanent
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:str. 772-780
Številčenje:Vol. 278, iss. 5
PID:20.500.12556/DiRROS-31479 Novo okno
UDK:61
ISSN pri članku:1528-1140
DOI:10.1097/SLA.0000000000006043 Novo okno
COBISS.SI-ID:161810947 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 18. 8. 2023;
Datum objave v DiRROS:03.08.2026
Število ogledov:66
Število prenosov:37
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Annals of surgery
Skrajšan naslov:Ann. surg.
Založnik:Lippincott, Williams & Wilkins
ISSN:1528-1140
COBISS.SI-ID:3542036 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Medtronic
Številka projekta:-
Naslov:Medtronic

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:onkologija


Nazaj